Edition:
United States

Sienna Biopharmaceuticals Inc (SNNA.OQ)

SNNA.OQ on NASDAQ Stock Exchange Global Select Market

23.75USD
3:59pm EST
Change (% chg)

$1.01 (+4.44%)
Prev Close
$22.74
Open
$22.75
Day's High
$23.97
Day's Low
$22.39
Volume
26,804
Avg. Vol
20,301
52-wk High
$28.95
52-wk Low
$17.42

Chart for

About

Sienna Biopharmaceuticals, Inc. is a United States-based medical dermatology and aesthetics company. The Company focuses on developing targeted therapies to treat inflammatory skin conditions and aesthetic concerns that impact the health and appearance of patients. Its research and clinical-stage candidates include programs,... (more)

Overall

Beta: --
Market Cap(Mil.): $467.05
Shares Outstanding(Mil.): 20.54
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.97 15.71
EPS (TTM): -- -- --
ROI: -- -11.84 31.93
ROE: -- -36.93 16.16

BRIEF-Sienna Biopharmaceuticals posts qtrly loss per share $1.12‍​

* Sienna Biopharmaceuticals reports third quarter 2017 financial results

Nov 09 2017

BRIEF-Sienna Biopharmaceuticals announces first patient dosed in phase 2B trial of topical SNA-120

* Sienna Biopharmaceuticals announces first patient dosed in phase 2B trial of topical SNA-120

Oct 24 2017

BRIEF-Sienna Biopharmaceuticals reports Q2 loss of $6.50/shr

* Sienna Biopharmaceuticals reports second quarter 2017 financial results

Sep 07 2017

BRIEF-Partner Fund reports 7.7 pct passive stake in Sienna Biopharmaceuticals‍​

* Partner Fund Management LP reports 7.7 percent passive stake in Sienna Biopharmaceuticals Inc as of July 27, 2017 - SEC filing‍​ Source text: (http://bit.ly/2vfsuuL) Further company coverage:

Aug 07 2017

BRIEF-Sienna Biopharmaceuticals shares open 27 pct above IPO price in debut

* Sienna Biopharmaceuticals Inc shares open at $19.05 in debut on the NASDAQ versus IPO price of $15.00

Jul 27 2017

Earnings vs. Estimates